Prime Medicine Inc (PRME)

08:53 AM

Prime Medicine appoints Matthew Hawryluk as chief business officer By Investing.com - Investing.com Australia

08:53 AM

06:28 AM

Levin Capital Strategies L.P. Increases Stock Holdings in Prime Medicine, Inc. $PRME - MarketBeat

06:28 AM

02:16 AM

Tick level data insight on Prime Medicine Inc. volatilityGold Moves & Daily Entry Point Alerts - newser.com

02:16 AM

01:35 AM

Is Prime Medicine Inc. stock a buy in volatile markets2025 Growth vs Value & Consistent Income Trade Recommendations - newser.com

01:35 AM

Nov 03, 2025

Prime Medicine Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer - citybiz

Nov 03, 2025

Nov 03, 2025

Prime Medicine (PRME) Competitors and Alternatives 2025 - MarketBeat

Nov 03, 2025

Nov 03, 2025

How institutional ownership impacts Prime Medicine Inc. stock2025 Stock Rankings & Smart Money Movement Tracker - newser.com

Nov 03, 2025

Nov 03, 2025

Prime Medicine appoints Matthew Hawryluk as chief business officer - Investing.com

Nov 03, 2025

Nov 03, 2025

Prime Medicine, Inc. Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer - Quiver Quantitative

Nov 03, 2025

Nov 03, 2025

Prime Medicine (NASDAQ: PRME) names Matthew Hawryluk CBO; >$2.5B in deals at Gritstone - Stock Titan

Nov 03, 2025

Nov 03, 2025

Why Prime Medicine Inc. stock appeals to analystsMarket Movement Recap & Weekly Market Pulse Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Will Prime Medicine Inc. stock outperform growth indexesMarket Growth Report & Low Drawdown Momentum Trade Ideas - newser.com

Nov 03, 2025

Nov 03, 2025

Smart tools for monitoring Prime Medicine Inc.’s price actionWeekly Investment Summary & Fast Exit and Entry Strategy Plans - newser.com

Nov 03, 2025

Nov 03, 2025

Price momentum metrics for Prime Medicine Inc. explainedMarket Risk Summary & Daily Market Momentum Tracking - newser.com

Nov 03, 2025

Nov 03, 2025

Is Prime Medicine Inc. stock supported by strong fundamentalsJuly 2025 News Drivers & Smart Money Movement Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

How Prime Medicine Inc. stock reacts to job market data2025 Momentum Check & Expert Curated Trade Setup Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

How Prime Medicine Inc. stock performs in weak economyJuly 2025 Spike Watch & Weekly Market Pulse Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Combining price and volume data for Prime Medicine Inc.Buy Signal & Technical Pattern Based Signals - newser.com

Nov 03, 2025

Nov 03, 2025

Momentum divergence signals in Prime Medicine Inc. chartMarket Trend Summary & Verified Swing Trading Watchlists - newser.com

Nov 03, 2025

Nov 02, 2025

Comparing Prime Medicine Inc. in custom built stock radarsWeekly Stock Recap & Consistent Growth Equity Picks - newser.com

Nov 02, 2025

Nov 02, 2025

Technical signs of recovery in Prime Medicine Inc.Market Risk Summary & Technical Confirmation Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

Prime Medicine’s Price Target Revision Sparks Market Interest - StocksToTrade

Nov 02, 2025

Nov 02, 2025

Prime Medicine Eyes Expansion with Strategic Partnerships and Investor Engagement - timothysykes.com

Nov 02, 2025

Nov 02, 2025

Prime Medicine, Inc. (NYSE:PRME) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Nov 02, 2025

Nov 01, 2025

Prime Medicine’s Investor Activities and Upcoming Developments Boost Market Interest - StocksToTrade

Nov 01, 2025

Nov 01, 2025

Prime Medicine Stock Poised for Strategic Growth With New Developments - timothysykes.com

Nov 01, 2025

Nov 01, 2025

Prime Medicine (NASDAQ:PRME) Shares Up 9.9%Time to Buy? - MarketBeat

Nov 01, 2025

Nov 01, 2025

Prime Medicine (NYSE:PRME) Trading 11.9% HigherWhat's Next? - MarketBeat

Nov 01, 2025

Nov 01, 2025

Sumitomo Mitsui Trust Group Inc. Has $3.94 Million Position in Prime Medicine, Inc. $PRME - MarketBeat

Nov 01, 2025

Oct 31, 2025

PRME Stock Surge: A Buying Opportunity? - StocksToTrade

Oct 31, 2025

Oct 31, 2025

Institutional investors in Prime Medicine, Inc. (NASDAQ:PRME) see US$174m decrease in market cap last week, although long-term gains have benefitted them. - Yahoo Finance

Oct 31, 2025

Oct 31, 2025

Does Prime Medicine Inc. qualify in momentum factor screeningEarnings Beat & Weekly High Potential Stock Alerts - newser.com

Oct 31, 2025

Oct 31, 2025

Using economic indicators to assess Prime Medicine Inc. potentialWeekly Profit Report & AI Based Buy and Sell Signals - newser.com

Oct 31, 2025

Oct 31, 2025

IQ EQ FUND MANAGEMENT IRELAND Ltd Reduces Stock Holdings in Prime Medicine, Inc. $PRME - MarketBeat

Oct 31, 2025

Oct 31, 2025

Published on: 2025-10-31 03:29:26 - newser.com

Oct 31, 2025

Oct 31, 2025

Can Prime Medicine Inc. stock outperform in 2025 bull marketTrend Reversal & Daily Technical Forecast Reports - newser.com

Oct 31, 2025

Oct 30, 2025

Prime Medicine to Host Virtual KOL Event to Showcase Wilson’s Disease Strategy - The Manila Times

Oct 30, 2025

Oct 30, 2025

Prime Medicine (NASDAQ: PRME) to file IND/CTA for PM577 in H1 2026 for Wilson’s Disease - Stock Titan

Oct 30, 2025

Oct 30, 2025

Cathie Wood’s ARK Investment buys 231K shares of Prime Medicine today - MSN

Oct 30, 2025